Form 4 for NVNO enVVeno Medical Corp
Accepted 2024-03-15 00:00:00 ET · period of report 2024-03-13 · accession 0001493152-24-010168 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-15 | 2024-03-13 | NVNO | Alavi Hamed | CTO | S - Sale+OE | $6.22 | -8,334 | 0 | -100% | -$51.8K |
| D | 2024-03-15 | 2024-03-13 | NVNO | Alavi Hamed | CTO | M - OptEx | $3.59 | +8,334 | 8,334 | New | +$29.9K |
| D | 2024-03-15 | 2024-03-13 | NVNO | Alavi Hamed | CTO | M - OptEx | $0.00 | -8,334 | 91.7K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-13 | S | D | 8,334 | $6.22 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-13 | M | A | 8,334 | $3.59 | 8,334 | D | — | — | |
| 3 | Derivative | Stock Options | 2024-03-13 | M | D | 8,334 | $0.00 | 91,666 | D | $3.59 · — to 2033-12-05 | 8,334 Common Stock | (F1) The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the Amended and Restated 2016 Omnibus Incentive Plan. The award is subject to time-based vesting and will vest in equal quarterly installments during the three calendar years through 2026. The portion of the stock options exercised in this transaction was fully vested and exercisable on the transaction date. |